{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:05:52Z","timestamp":1780632352848,"version":"3.54.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/1476-0711-1-1","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T12:58:50Z","timestamp":1034081930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report"],"prefix":"10.1186","volume":"1","author":[{"given":"Deniz","family":"G\u00f6kengin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tansu","family":"Yamazhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,9,16]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/jama.283.1.74","volume":"43","author":"R Reisler","year":"2001","unstructured":"Reisler R, Liou S, Servoss J, Robbins G, Theodore D, Murphy R, Chung R: Incidence of hepatotoxicity and mortality in 21 adult antiretroviral treatment trials. Program and abstracts of The 1st IAS Conference on HIV Pathogenesis and Treatment; Buenos Aires, Argentina. Abstract 43-July 8\u201311, 2001 10.1001\/jama.283.1.74","journal-title":"Program and abstracts of The 1st IAS Conference on HIV Pathogenesis and Treatment"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jama.283.1.74","volume":"283","author":"MS Sulkowski","year":"2000","unstructured":"Sulkowski MS, Thomas DL, Chaisson RE, Moore RD: Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of Hepatitis C or B virus infection. JAMA. 2000, 283: 74-80. 10.1001\/jama.283.1.74","journal-title":"JAMA"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1001\/jama.284.21.2722","volume":"284","author":"S Johnson","year":"2000","unstructured":"Johnson S, Baraboutis JG: Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA. 2000, 284: 2722-2723. 10.1001\/jama.284.21.2722","journal-title":"JAMA"},{"key":"1_CR4","first-page":"1997","volume":"49","author":"Centers for Disease Control","year":"2000","unstructured":"Centers for Disease Control: Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures-Worldwide, MMWR. 2000, 49: 1997-2001.","journal-title":"MMWR"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/00002030-200107060-00007","volume":"15","author":"E Martinez","year":"2001","unstructured":"Martinez E, Blanco JL, Arnaiz JA, Perez-Cuevas JB, Mocroft A, Cruceta A, Marcos MA, Milinkovic A, Garcia-Viejo MA, Mallolas J: Hepatotoxicity in HIV-1 infected patients receiving nevirapine-containing antiretroviral therapy. AIDS. 2001, 15: 1261-1268. 10.1097\/00002030-200107060-00007","journal-title":"AIDS"},{"key":"1_CR6","first-page":"8","volume":"44","author":"D Dieterich","year":"2001","unstructured":"Dieterich D, Stern J, Robinson P, Hall D, Carlier H: Analyses of four key clinical trials to assess the risk of hepatotoxicity with nevirapine: Correlation with CD4+ levels, hepatitis B and C seropositivity, and baseline liver function tests. Program and abstracts of The 1st IAS Conference on HIV Pathogenesis and Treatment; Buenos Aires, Argentina. Abstract 44-July 8\u201311, 2001","journal-title":"Abstract"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1086\/317449","volume":"31","author":"EH Gisolf","year":"2000","unstructured":"Gisolf EH, Dreezen C, Danner SA, Weel JL, Weverling GJ: Risk factors for hepatotoxicity in HIV-1 infected patients receiving ritonavir and saquinavir with or without stavudine, Prometheus Study Group. Clin Infect Dis. 2000, 31: 1234-1239. 10.1086\/317449","journal-title":"Clin Infect Dis"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/j.1572-0241.2001.03779.x","volume":"96","author":"M Prakash","year":"2001","unstructured":"Prakash M, Vijayrama P, Tiyyagura L, Bonacini M: Jaundice and hepatocellular damage associated with nevirapine therapy. Am J Gastroenterol. 2001, 96: 1571-1574. 10.1016\/S0002-9270(01)02342-5","journal-title":"Am J Gastroenterol"},{"key":"1_CR9","first-page":"379","volume":"11","author":"PJ Piliero","year":"2001","unstructured":"Piliero PJ, Purdy B: Nevirapine-induced hepatitis: a case series and review of the literature. AIDS Read. 2001, 11: 379-382.","journal-title":"AIDS Read"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004850-199100620-00004","volume":"6","author":"M Davis","year":"1991","unstructured":"Davis M: Hepatotoxicity of antidepressants. Int Clin Psychopharmacol. 1991, 6: 97-103.","journal-title":"Int Clin Psychopharmacol"},{"key":"1_CR11","first-page":"199","volume":"10","author":"P Dostert","year":"1984","unstructured":"Dostert P, Benedetti MS: Biochemical mechanisms of the hepatotoxicity of psychotropic drugs. Encephale. 1984, 10: 199-209.","journal-title":"Encephale"},{"key":"1_CR12","first-page":"199","volume":"10","author":"Panel on Clinical Practices for the Treatment of HIV","year":"1984","unstructured":"Panel on Clinical Practices for the Treatment of HIV: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. August 13, 2001, http:\/\/www.hivatis.org\/trtgdlns.html#Adult","journal-title":"Encephale"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-0711-1-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:14:56Z","timestamp":1726240496000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/1476-0711-1-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,16]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,1]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1186\/1476-0711-1-1","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,16]]},"assertion":[{"value":"7 August 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}